Trump rolls back Biden directive to study methods of lowering prescription costs
- President Donald Trump revoked an executive order by former President Joe Biden that aimed to lower prescription drug costs for people on Medicare and Medicaid, as confirmed by multiple sources.
- The rescission of Biden's order creates uncertainty regarding future federal efforts to lower drug prices, although it does not immediately change existing laws.
- Democratic Senator Adam Schiff stated that Trump's action will increase prescription drug costs for Americans on Medicare and Medicaid, affecting over 120 million people.
- Experts suggest that while the immediate impact on drug prices may be limited, Trump's decision could allow drug companies to raise prices more easily in the future.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left5Leaning Right0Center6Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
L 46%
C 54%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage